We are pleased to announce the International Live Conference on Drug Discovery, scheduled to be held on March 16, 2024, at 08:00 PM Indian Standard Time, in an online format. The conference will be focused on the theme, "Innovating the Future of Drug Discovery: Emerging Technologies and Novel Approaches," which aims to highlight the latest advancements in the field of drug discovery, with special emphasis on cutting-edge technologies and innovative approaches.

In addition to the main theme, the conference will also have a special track dedicated to brain and mental disorders. This track will provide a unique platform for researchers and experts to present and discuss their latest findings in the field of neuroscience, including new drug discoveries, emerging therapies, and their potential applications in the treatment of mental health disorders. The special track aims to explore the challenges and opportunities in drug discovery for brain and mental disorders, and to foster collaboration between researchers and industry professionals working in this important area. We look forward to an engaging and informative conference that will have a positive impact on drug discovery research globally.

Sessions:

Emerging Technologies in Drug Discovery: AI and Machine Learning
Novel Approaches in Drug Design and Discovery
Therapeutic Strategies for Brain and Mental Disorders: New Discoveries and Current Challenges
Preclinical Development and Clinical Trials: Lessons Learned and Best Practices
Drug Delivery and Formulation: Novel Approaches to Enhance Efficacy and Safety
Innovations in Precision Medicine: Opportunities and Challenges in Personalized Drug Discovery
Regulatory and Ethical Considerations in Drug Discovery and Development
Investor and Industry Perspectives on Drug Discovery: Opportunities and Challenges
The Future of Drug Discovery: Perspectives and Prospects

Our conference will feature a range of sessions, including presentations, posters, and interactive discussions, that will provide attendees with opportunities to engage with the latest research and advances in drug discovery. By participating in this conference, we hope to facilitate collaborations and inspire new ideas that will lead to better diagnosis, treatment, and care for individuals with brain and mental problems.

Thank you for your interest in this conference, and we look forward to your participation in this exciting event.

Publicly Available Financial Data on Drug Discovery and Development for Brain and Mental Disorders

The National Institute of Mental Health (NIMH) spent approximately $1.9 billion on research related to mental health in 2020, which includes funding for drug discovery and development. You can find more information on NIMH funding at: https://report.nih.gov/categorical_spending.aspx
According to a report by the Pharmaceutical Research and Manufacturers of America (PhRMA), member companies spent $83 billion on research and development in 2019, including investments in treatments for neurological and psychiatric disorders. You can find more information on PhRMA's annual report at: https://www.phrma.org/annual-report
The World Health Organization (WHO) estimates that the global economic burden of mental illness is $2.5 trillion per year, which includes the costs of healthcare, lost productivity, and other indirect costs. You can find more information on WHO's data on global health expenditures at: https://www.who.int/data/gho/data/themes/health-expenditure.
The National Institutes of Health (NIH) provides data on the funding for research related to neurological and psychiatric disorders, including drug discovery and development. In 2020, the NIH spent approximately $1.8 billion on research related to neuroscience and behavior. You can find more information on NIH funding at: https://report.nih.gov/categorical_spending.aspx.
The National Alliance on Mental Illness (NAMI) estimates that the total economic cost of untreated mental illness in the United States is over $300 billion per year, which includes healthcare costs, lost productivity, and other indirect costs. You can find more information on NAMI's data on mental health spending at: https://www.nami.org/About-NAMI/Publications-Reports/Public-Policy-Reports/The-Economic-Burdens-of-Excessively-Low-Wages-for-Direct-Support-Professionals.

Title: The International Live Conference on Drug Discovery
Date: March 16, 2024
Time: 8 PM Indian Standard Time
Location: Online
Conference Theme: Innovating the Future of Drug Discovery: Emerging Technologies and Novel Approaches

Title: International Live Conference on Drug Discovery

Date: March 16, 2024

Time: 8:00 PM Indian Standard Time

Location: Online

Conference Theme: Innovating the Future of Drug Discovery through Emerging Technologies and Novel Approaches

We are delighted to announce the International Live Conference on Drug Discovery, slated for March 16, 2024, at 8:00 PM Indian Standard Time, to be conducted online. The conference will revolve around the theme, "Innovating the Future of Drug Discovery: Emerging Technologies and Novel Approaches," aiming to showcase the latest advancements in drug discovery, with a specific focus on cutting-edge technologies and inventive methodologies.

In addition to the primary theme, a dedicated special track will focus on brain and mental disorders. This track provides a unique platform for researchers and experts to share and discuss their recent findings in neuroscience, covering new drug discoveries, emerging therapies, and their potential applications in treating mental health disorders. The special track aims to delve into the challenges and opportunities in drug discovery for brain and mental disorders, fostering collaboration between researchers and industry professionals. We anticipate an engaging and enlightening conference that will positively impact global drug discovery research.

Conference Sessions:

1. Emerging Technologies in Drug Discovery: AI and Machine Learning

2. Novel Approaches in Drug Design and Discovery

3. Therapeutic Strategies for Brain and Mental Disorders: New Discoveries and Current Challenges

4. Preclinical Development and Clinical Trials: Lessons Learned and Best Practices

5. Drug Delivery and Formulation: Novel Approaches to Enhance Efficacy and Safety

6. Innovations in Precision Medicine: Opportunities and Challenges in Personalized Drug Discovery

7. Regulatory and Ethical Considerations in Drug Discovery and Development

8. Investor and Industry Perspectives on Drug Discovery: Opportunities and Challenges

9. The Future of Drug Discovery: Perspectives and Prospects

The conference will feature various sessions, including presentations, posters, and interactive discussions, providing attendees with opportunities to engage with the latest research and advances in drug discovery. Our goal is to facilitate collaborations and inspire new ideas that contribute to improved diagnosis, treatment, and care for individuals with brain and mental health issues.

Don't miss the chance to be part of this transformative event in Drug Discovery. Register now for the International Live Conference on Drug Discovery and join the global community of experts advancing neurological research and patient care.

Event Highlights:

1. Live Streaming: Join us on LinkedIn for real-time engagement and interaction during the conference.

2. YouTube Recording: Can't make it live? Don't worry! All sessions will be recorded and available on our YouTube channel for later viewing.

For registration details, click here.

We eagerly anticipate your active participation and engagement in this groundbreaking event! If you have any questions, feel free to email us at conferences@olcias.com.

Publicly Available Financial Data on Drug Discovery and Development for Brain and Mental Disorders

The National Institute of Mental Health (NIMH) spent approximately $1.9 billion on research related to mental health in 2020, which includes funding for drug discovery and development. You can find more information on NIMH funding at: https://report.nih.gov/categorical_spending.aspx
According to a report by the Pharmaceutical Research and Manufacturers of America (PhRMA), member companies spent $83 billion on research and development in 2019, including investments in treatments for neurological and psychiatric disorders. You can find more information on PhRMA's annual report at: https://www.phrma.org/annual-report
The World Health Organization (WHO) estimates that the global economic burden of mental illness is $2.5 trillion per year, which includes the costs of healthcare, lost productivity, and other indirect costs. You can find more information on WHO's data on global health expenditures at: https://www.who.int/data/gho/data/themes/health-expenditure.
The National Institutes of Health (NIH) provides data on the funding for research related to neurological and psychiatric disorders, including drug discovery and development. In 2020, the NIH spent approximately $1.8 billion on research related to neuroscience and behavior. You can find more information on NIH funding at: https://report.nih.gov/categorical_spending.aspx.
The National Alliance on Mental Illness (NAMI) estimates that the total economic cost of untreated mental illness in the United States is over $300 billion per year, which includes healthcare costs, lost productivity, and other indirect costs. You can find more information on NAMI's data on mental health spending at: https://www.nami.org/About-NAMI/Publications-Reports/Public-Policy-Reports/The-Economic-Burdens-of-Excessively-Low-Wages-for-Direct-Support-Professionals.